Published in Helicobacter on August 01, 2008
Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology (2009) 2.22
Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. Gastroenterology (2015) 1.85
Gastric carcinogenesis. Langenbecks Arch Surg (2011) 1.08
Influence of dietary components on regulatory T cells. Mol Med (2012) 1.01
Pattern-recognition receptors and gastric cancer. Front Immunol (2014) 0.95
TLR2 mediates Helicobacter pylori-induced tolerogenic immune response in mice. PLoS One (2013) 0.93
Role of gastric epithelial cell-derived transforming growth factor beta in reduced CD4+ T cell proliferation and development of regulatory T cells during Helicobacter pylori infection. Infect Immun (2011) 0.91
Cytotoxic T cells in H. pylori-related gastric autoimmunity and gastric lymphoma. J Biomed Biotechnol (2010) 0.90
Helicobacter pylori colonization ameliorates glucose homeostasis in mice through a PPAR γ-dependent mechanism. PLoS One (2012) 0.90
The role of natural regulatory T cells in infection. Immunol Res (2011) 0.84
Helicobacter pylori infection and inflammatory bowel disease: is there a link? World J Gastroenterol (2014) 0.83
Increased numbers of Foxp3-positive regulatory T cells in gastritis, peptic ulcer and gastric adenocarcinoma. World J Gastroenterol (2012) 0.82
Distribution of CD4(pos) -, CD8(pos) - and regulatory T cells in the upper and lower gastrointestinal tract in healthy young subjects. PLoS One (2013) 0.80
The interleukin-17 receptor B subunit is essential for the Th2 response to Helicobacter pylori, but not for control of bacterial burden. PLoS One (2013) 0.79
Chronic mucosal inflammation of the gastric cardia in gastroesophageal reflux disease is not regulated by FOXP3-expressing T cells. Dig Dis Sci (2009) 0.79
Helicobacter pylori vaccination: is there a path to protection? World J Gastroenterol (2014) 0.78
Association between the TGFB1 -509C/T and TGFBR2 -875A/G polymorphisms and gastric cancer: a case-control study. Oncol Lett (2011) 0.78
The similarity of Type 1 autoimmune pancreatitis to pancreatic ductal adenocarcinoma with significant IgG4-positive plasma cell infiltration. J Gastroenterol (2012) 0.78
At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer. J Leukoc Biol (2014) 0.78
Cytokines, cytokine gene polymorphisms and Helicobacter pylori infection: friend or foe? World J Gastroenterol (2014) 0.77
Plasmodium yoelii infection of BALB/c mice results in expansion rather than induction of CD4(+) Foxp3(+) regulatory T cells. Immunology (2016) 0.77
Mechanisms of modulation of cytokine release by human cord blood monocytes exposed to high concentrations of caffeine. Pediatr Res (2016) 0.76
DC-LAMP+ dendritic cells are recruited to gastric lymphoid follicles in Helicobacter pylori-infected individuals. Infect Immun (2013) 0.76
Host pathogen interactions in Helicobacter pylori related gastric cancer. World J Gastroenterol (2017) 0.75
CCR2 mediates Helicobacter pylori-induced immune tolerance and contributes to mucosal homeostasis. Helicobacter (2016) 0.75
Helicobacter, Hygiene, Atopy, and Asthma. Front Microbiol (2017) 0.75
FoxP3(+) T regulatory cells in oral lichen planus and its correlation with the distinct clinical appearance of the lesions. Int J Exp Pathol (2012) 0.75
Cooperation of Gastric Mononuclear Phagocytes with Helicobacter pylori during Colonization. J Immunol (2017) 0.75
Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology (2004) 4.24
Hepatocellular carcinoma--epidemiological trends and risk factors. Dig Dis (2009) 2.82
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease. Clin Chim Acta (2010) 2.31
Identification of clinical and laboratory markers for predicting eosinophilic esophagitis in adults. Digestion (2011) 2.15
Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol (2004) 2.09
Adenocarcinomas at different positions at the gastro-oesophageal junction show distinct association with gastritis and gastric preneoplastic conditions. Eur J Gastroenterol Hepatol (2015) 2.00
Therapeutic ERCP with the double-balloon enteroscope in patients with Roux-en-Y anastomosis. Gastrointest Endosc (2008) 1.92
Thymoquinone: a promising anti-cancer drug from natural sources. Int J Biochem Cell Biol (2005) 1.67
Proteinase-activated receptor-2 in the pathogenesis of gastroesophageal reflux disease. Am J Gastroenterol (2010) 1.62
Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease. Am J Gastroenterol (2006) 1.62
Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. Int J Oncol (2004) 1.60
Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease. FASEB J (2004) 1.57
STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. Am J Gastroenterol (2007) 1.54
World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective. J Gastrointestin Liver Dis (2010) 1.52
Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms are not associated with premalignant gastric conditions: a combined haplotype analysis. Eur J Gastroenterol Hepatol (2010) 1.52
Hepatocellular carcinoma (HCC): a global perspective. J Clin Gastroenterol (2010) 1.49
Exocrine and endocrine pancreatic insufficiency after pancreatic surgery. Best Pract Res Clin Gastroenterol (2004) 1.47
Synchronous multifocal colorectal carcinoma in a patient with delayed diagnosis of ulcerative pancolitis. Pathol Res Pract (2008) 1.47
[Diagnostic and therapeutic utility of double balloon endoscopy: experience with 225 procedures]. Acta Gastroenterol Latinoam (2007) 1.45
Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26. Am J Gastroenterol (2005) 1.43
Procaine hydrochloride fails to relieve pain in patients with acute pancreatitis. Digestion (2004) 1.42
Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients. Eur J Gastroenterol Hepatol (2008) 1.42
Expression of c-MET, low-molecular-weight cytokeratin, matrix metalloproteinases-1 and -2 in spinal chordoma. Histopathology (2009) 1.41
Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease. J Biol Chem (2005) 1.39
Does H. pylori eradication therapy benefit patients with hepatic encephalopathy?: systematic review. J Clin Gastroenterol (2014) 1.39
Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis. Neoplasia (2005) 1.38
Digital pathology: DICOM-conform draft, testbed, and first results. Comput Methods Programs Biomed (2007) 1.38
The submucosal cushion does not improve the histologic evaluation of adenomatous colon polyps resected by snare polypectomy. Clin Gastroenterol Hepatol (2011) 1.37
Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery. Cardiovasc Res (2002) 1.37
Endoscopic retrograde cholangiopancreatography using the single balloon enteroscope technique in patients with Roux-en-Y anastomosis. Digestion (2009) 1.35
Molecular analysis of APC promoter methylation and protein expression in colorectal cancer metastasis. Carcinogenesis (2004) 1.33
The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer. Int J Oncol (2005) 1.31
ERCP with the double balloon enteroscope in patients with Roux-en-Y anastomosis. Surg Endosc (2008) 1.31
Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo. Hepatology (2006) 1.28
5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms. J Pharmacol Exp Ther (2004) 1.27
Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas. Gastroenterology (2006) 1.26
Does the treatment of gastroesophageal reflux disease (GERD) meet patients' needs? A survey-based study. Curr Med Res Opin (2006) 1.25
Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease. J Clin Microbiol (2004) 1.25
Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells. Cancer Biol Ther (2007) 1.23
Identification of gastric cancer patients by serum protein profiling. J Proteome Res (2004) 1.23
Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation. Circulation (2002) 1.23
Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study. Clin Cancer Res (2005) 1.22
Advanced colon polypectomy. Clin Gastroenterol Hepatol (2009) 1.22
Loss of beta-catenin expression in metastatic gastric cancer. J Clin Oncol (2003) 1.22
K-ras mutation detection in colorectal cancer using the Pyrosequencing technique. Pathol Res Pract (2007) 1.21
Macro-role of microRNA in gastric cancer. Dig Dis (2012) 1.20
Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol (2012) 1.18
Virtual 3D microscopy using multiplane whole slide images in diagnostic pathology. Am J Clin Pathol (2008) 1.18
Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection. Digestion (2013) 1.17
Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. J Med Microbiol (2002) 1.17
Glatiramer acetate induced acute exacerbation of autoimmune hepatitis in a patient with multiple sclerosis. J Neurol (2007) 1.16
G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer. Breast Cancer Res Treat (2011) 1.15
Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancers. Neoplasia (2005) 1.15
Advances, challenges, and limitations in serum-proteome-based cancer diagnosis. J Proteome Res (2006) 1.14
Importance of DNA damage checkpoints in the pathogenesis of human cancers. Pathol Res Pract (2010) 1.14
Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues. J Pathol (2002) 1.13
Amyloidosis of the breast. Virchows Arch (2001) 1.13
A group-specific PCR assay for the detection of Helicobacteraceae in human gut. Helicobacter (2002) 1.13
Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells. Breast Cancer Res Treat (2009) 1.13
A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia. J Support Oncol (2008) 1.11
Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells. Cancer Res (2008) 1.11
Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer. Oncotarget (2011) 1.11
Drug treatment of functional dyspepsia. World J Gastroenterol (2006) 1.11
A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis. Clin Gastroenterol Hepatol (2007) 1.10
Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models. J Cell Mol Med (2008) 1.10
World Gastroenterology Organisation global guideline: Constipation--a global perspective. J Clin Gastroenterol (2011) 1.10
Detection of neuroendocrine tumors of the small bowel by double balloon enteroscopy. Dig Dis Sci (2008) 1.09
Helicobacter pylori research: historical insights and future directions. Nat Rev Gastroenterol Hepatol (2013) 1.09
Risk factors for failure of endoscopic stenting of biliary strictures in chronic pancreatitis: a prospective follow-up study. Am J Gastroenterol (2003) 1.09
Serological assessment of gastric mucosal atrophy in gastric cancer. BMC Gastroenterol (2012) 1.09
KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal origin. Hum Pathol (2003) 1.08
Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma. Pathol Res Pract (2010) 1.08
Gastric carcinogenesis. Langenbecks Arch Surg (2011) 1.08
Overexpression of cathepsin B in gastric cancer identified by proteome analysis. Proteomics (2005) 1.08
A two-step method for the extraction of high-quality RNA from endoscopic biopsies. Clin Chem Lab Med (2003) 1.07